Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
Fassas
A B
AB
Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Tricot
G
G
D000206:Actuarial Analysis; D000208:Acute Disease; D000328:Adult; D000477:Alkylating Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001773:Blood Cells / Q000637:transplantation; D016026:Bone Marrow Transplantation; D002869:Chromosome Aberrations; D002999:Clone Cells / Q000473:pathology; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D007951:Leukemia, Myeloid / Q000209:etiology* / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy; D007953:Leukemia, Radiation-Induced / Q000209:etiology; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016296:Mutagenesis; D009190:Myelodysplastic Syndromes / Q000209:etiology* / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy; D016609:Neoplasms, Second Primary / Q000209:etiology / Q000235:genetics / Q000401:mortality / Q000473:pathology / Q000628:therapy; D012189:Retrospective Studies; D012307:Risk Factors; D019172:Transplantation Conditioning / Q000009:adverse effects; D014182:Transplantation, Autologous / Q000009:adverse effects; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation / Q000009:adverse effects
D000477:Alkylating Agents; D000970:Antineoplastic Agents